繁體版 / 簡體版
 
ABOUT US
/ OVERVIEW

OVERVIEW

    MICROBIO, which was founded in 2000, has experienced over a decade of growth and remains dedicated to “novel therapeutics development and human lifestyle improvement”. MICROBIO Group’s approach to innovative and responsible drug development has led to two successful drug approvals by the Taiwanese Food and Drug Administration (TFDA). In addition to drug development, we have expanded into other markets such as top-line medical devices, functional health foods, organic agricultural products, and biotechnology venture capital. We always welcome strategic collaborations with leading research institutions, international pharmaceutical companies, and novel biotechnology platforms, all of which allow us to bridge gaps in medical treatments. It is our mission to fulfill unmet healthcare needs, and transform scientific breakthroughs into clinical research in the hopes of providing new treatment options for patients. Our core values, modesty and innovation, drive us to take initiative, stay competitive, and position us as an influential leader in the global market.


体彩p5中奖新闻 bbin金沙app下载 世界上知名的五个股票指数 浪潮软件股票行情 山西十一选五前三走势图 甘肃十一选五走势图今天 海南飞鱼彩票开奖号码 一分彩官网 北京体彩网-快中彩 秒速赛车有什么好公式 山西快乐10分投注平台